T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas (NCT07447531)
Evaluating Iron-Dependent Biomarkers of Malignant Glioma (WHO Grade IV) Progression
🩺 Plain-English Summary (8th-Grade Level)
This clinical trial studies whether T2 star (T2\*) magnetic resonance imaging (MRI) and biomarker blood testing can help predict how World Health Organization (WHO) grade IV gliomas (malignant gliomas) might change or progress over time.
Who can join: Review the eligibility criteria below.
Location: University of Iowa Health Care — Iowa City, Iowa
Age range: 21 Years
🧪 Interventions in This Study
- T2 (Observed)-Weighted Imaging (PROCEDURE)
- Biospecimen Collection (PROCEDURE)
- Magnetic Resonance Imaging (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Iowa Health Care — Iowa City, Iowa
📞 Contact the Study Coordinator
Phone: (319) 356-7590
Email: john-buatti@uiowa.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Malignant Glioma
- A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas — Rochester, Minnesota
- Fitness and Nutrition in Glioma — New York, New York
- Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG — Phoenix, Arizona
- D2C7-IT With Atezolizumab for Recurrent Gliomas — Durham, North Carolina
- Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas. — Stony Brook, New York
- Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma — Houston, Texas
Explore by condition: All Malignant Glioma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.